1784874895 gettyimages 2200929852

FDA panel reviewing some peptides to consider loosening regulations for unapproved therapies

A Food and Drug Administration advisory panel voted to broaden access to at least one peptide during a two-day meeting discussing whether compounding pharmacies can fill prescriptions for some unapproved peptides. The meeting comes during a surge of interest in the unapproved therapies. Peptides are short strings of amino acids, the building blocks of proteins, linked by…

Read More
gettyimages 2202467589

Antihistamine recall across the U.S. triggered by heartburn drug contamination risk, FDA says

A generic version of the brand-name allergy medication Zyrtec is under recall across the U.S. due to potential cross-contamination with a heartburn drug, according to the Food and Drug Administration.  Drugmaker Unique Pharmaceutical Laboratories is voluntarily recalling antihistamine drugs, commonly used to treat seasonal allergies, over potential cross-contamination with ranitidine, a heartburn drug. Unique Pharmaceutical…

Read More